Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Hypoxic signaling during tissue repair and regenerative medicine

Nauta TD., van Hinsbergh VW., Koolwijk P.

Narrative Review on Chronic Wound, published in Int J Mol Sci (2014) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Mol Sci (2014)
Reported sample size
—
Source database
Europe PMC
PMID
25365172
PMCID
PMC4264139
DOI
10.3390/ijms151119791
Citations
66

Abstract (original English)

In patients with chronic wounds, autologous tissue repair is often not sufficient to heal the wound. These patients might benefit from regenerative medicine or the implantation of a tissue-engineered scaffold. Both wound healing and tissue engineering is dependent on the formation of a microvascular network. This process is highly regulated by hypoxia and the transcription factors hypoxia-inducible factors-1α (HIF-1α) and -2α (HIF-2α). Even though much is known about the function of HIF-1α in wound healing, knowledge about the function of HIF-2α in wound healing is lacking. This review focuses on the function of HIF-1α and HIF-2α in microvascular network formation, wound healing, and therapy strategies.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansTissue EngineeringRegenerative MedicineWound HealingSignal TransductionNeovascularization, PhysiologicHypoxia-Inducible Factor-Proline DioxygenasesHypoxiaBasic Helix-Loop-Helix Proteins

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research